# Church & Dwight Co Inc: Form 10-Q for the period ended Mar 31, 2013

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2013-05-02
- Accepted by EDGAR: May 2, 2013, 18:53 ET
- Period: 2013-03-31
- Accession: 0001193125-13-195736
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000119312513195736/d508285d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000119312513195736/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-01-01 to 2013-03-31 | $779.3m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2013-01-01 to 2013-03-31 | $429.2m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2013-01-01 to 2013-03-31 | $350.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2013-01-01 to 2013-03-31 | $14.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2013-01-01 to 2013-03-31 | $101.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-01-01 to 2013-03-31 | $169.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-01-01 to 2013-03-31 | $7.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-01-01 to 2013-03-31 | $55.5m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2013-01-01 to 2013-03-31 | $0.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-01-01 to 2013-03-31 | $0.78 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-01-01 to 2013-03-31 | 140,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2013-01-01 to 2013-03-31 | $72.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2013-01-01 to 2013-03-31 | $10.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2013-01-01 to 2013-03-31 | $38.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2013-01-01 to 2013-03-31 | $50.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-03-31 | $259.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-03-31 | $911.8m | us-gaap:AssetsCurrent |
| Total assets | at 2013-03-31 | $4.06bn | us-gaap:Assets |
| Current liabilities | at 2013-03-31 | $655.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-03-31 | $1.98bn | us-gaap:Liabilities |
| Long-term debt | at 2013-03-31 | $649.4m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2013-03-31 | $203.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2013-03-31 | $2.09bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,960 characters.

### Results of Operations

#### Consolidated Results

#### Net Sales

Net sales for the quarter ended March 31, 2013 were $779.3 million, $88.7 million or 12.8% over the first quarter of 2012. The components of the net sales increase are the following:

| Net Sales - Consolidated | Three Months Ended March 31, 2013 |
| --- | ---: |
| Product volumes sold | 2.4% |
| Pricing/Product mix | (0.4%) |
| Foreign exchange rate fluctuations | (0.4%) |
| Acquired product lines(1) | 9.9% |
| Sales in anticipation of information systems upgrade | 1.3% |
| **Net Sales increase** | **12.8%** |

(1) On October 1, 2012, Church & Dwight Co., Inc. ( the “Company”) acquired Avid Health, Inc. (“Avid Health”). Net sales of the acquired product lines subsequent to the acquisition are included in the Company’s results.

The volume change primarily reflects increased sales of products in both the Consumer Domestic and Consumer International segments. Unfavorable product mix and pricing primarily in Consumer Domestic had an impact on total net sales. Sales in the first quarter of 2012 were negatively impacted due to a timing shift in customer orders from the first quarter of 2012 to the fourth quarter of 2011 in anticipation of the January 1, 2012 information systems upgrade in the U.S.

#### Operating Costs

The Company’s gross profit was $350.1 million for the quarter ended March 31, 2013, a $47.6 million increase as compared to the same period in 2012. The gross profit increase was primarily attributable to contributions from the acquired product lines, higher sales volumes, in-house production of unit dose detergent and productivity improvement programs, partially offset by unfavorable pricing and mix and the unfavorable effect of foreign exchange rates. Gross margin increased 110 basis points to 44.9% in the first quarter as compared to 43.8% in the same quarter last year. Gross margin was higher due to the positive impact of productivity improvement programs, partially offset by the effect of the Avid Health acquisition, whose products have a lower gross margin than the Company average. Commodity costs were flat in the quarter versus the prior year first quarter.

Marketing expenses for the first quarter of 2013 were $78.9 million, an increase of $10.9 million as compared to the same period in 2012 due primarily to the effect of the acquired product lines and higher spending in support of certain of its power brands. Marketing expenses as a percentage of net sales were 10.1% in the first quarter of 2013 as compared to 9.8% in the same period in 2012.

Selling, general and administrative expenses (“SG&A”) were $101.9 million in the first quarter of 2013, an increase of $10.1 million as compared to the same period in 2012 due to operating and transition costs associated with the Avid Health acquisition, higher research and development costs and a cease use charge associated with the Company’s Princeton leased buildings, partially offset by lower legal and information systems expenses. SG&A as a percentage of net sales was 13.1% in the first quarter of 2013, a 20 basis point reduction from the first quarter of 2012, which reflects SG&A leverage associated with the Avid Health acquisition.

#### Other Income and Expenses

Equity in earnings of affiliates was $0.6 million in the first quarter of 2013 as compared to $2.5 million in the same period in 2012. The decrease is due principally to lower earnings from Armand as a result of increased raw material costs.

Interest expense in the first quarter of 2013 increased $4.3 million compared to the same period in 2012 primarily due to the debt incurred to finance the acquisition of Avid Health.

#### Taxation

The effective tax rate in the first quarter of 2013 was 34.0% as compared to 33.1% in the first quarter of 2012. The effective tax rate in the first quarter of 2013 was favorably affected by a tax benefit relating to the retroactive extension of a research tax credit. The effective tax rate in the first quarter of 2012 was favorably affected by the settlement of an IRS audit. The 2013 annual effective tax rate is projected to be approximately 35%.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”). These segments are determined based on differences in the nature of products and organizational and ownership structures. The results of Avid Health are reflected in the Consumer Domestic segment. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of March 31, 2013, the Company had 50% ownership interests in Armand Products Company (“Armand”), The ArmaKleen Company (“ArmaKleen”), and a one-third ownership interest in Natronx Technologies, LLC (“Natronx”). The Company’s equity in earnings or losses of Armand, ArmaKleen and Natronx for the three months ended March 31, 2013 and March 31, 2012 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment Net Sales and Income Before Income Taxes for the three months ended March 31, 2013 and March 31, 2012 were as follows:

*(In millions)*

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **First Quarter 2013** | **$591.0** | **$129.3** | **$59.0** | **$0.0** | **$779.3** |
| First Quarter 2012 | 510.6 | 121.4 | 58.6 | 0.0 | 690.6 |
| **Income Before Income Taxes(2)** |  |  |  |  |  |
| **First Quarter 2013** | **$134.0** | **$21.6** | **$7.0** | **$0.6** | **$163.2** |
| First Quarter 2012 | 112.2 | 21.8 | 6.7 | 2.5 | 143.2 |

(1) Intersegment sales from Consumer International to Consumer Domestic were $0.9 million and $1.1 million for the quarters ended March 31, 2013 and March 31, 2012, respectively.

(2) In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among the segments based upon each segment’s relative operating profit.

(3) Corporate consists of equity in earnings (loss) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues for external customers for the quarters ended March 31, 2013 and March 31, 2012 were as follows:

*(In millions)*

|  | Three Months Ended March 31, 2013 | March 31, 2012 |
| --- | ---: | ---: |
| Household Products | **$358.7** | $347.6 |
| Personal Care Products | **232.3** | 163.0 |
| Total Consumer Domestic | **591.0** | 510.6 |
| Total Consumer International | **129.3** | 121.4 |
| Total SPD | **59.0** | 58.6 |
| **Total Consolidated Net Sales** | **$779.3** | $690.6 |

Household Products include deodorizing, cleaning and laundry products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and vitamin and mineral supplements.

### Consumer Domestic

Consumer Domestic net sales in the first quarter of 2013 were $591.0 million, an increase of $80.4 million or 15.7% compared to net sales of $510.6 million in 2012. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended March 31, 2013 |
| --- | ---: |
| Product volumes sold | 1.8% |
| Pricing/Product mix | (0.4%) |
| Acquired product lines(1) | 12.8% |
| Sales in anticipation of information systems upgrade | 1.5% |
| **Net Sales increase** | **15.7%** |

(1) On October 1, 2012, the Company acquired Avid Health. Net sales of acquired product lines subsequent to the acquisition are included in Consumer Domestic results.

The increase in net sales reflects sales from the Avid Health acquisition and higher sales of ARM & HAMMER liquid laundry detergent, OXICLEAN laundry and dishwasher additives, TROJAN condoms and lubricants, ARM & HAMMER CRYSTAL BURST unit dose laundry detergent, ARM & HAMMER baking soda and ARM & HAMMER TOOTH TUNES toothbrushes. These increases were partially offset by lower sales of ARM & HAMMER powder laundry detergent, SPINBRUSH battery-operated toothbrushes, KABOOM cleaning products and XTRA liquid laundry detergent. Sales in the first quarter of 2012 were negatively impacted due to a timing shift in customer orders from the first quarter of 2012 to the fourth quarter of 2011 in anticipation of the January 1, 2012 information systems upgrade in the U.S. Since the introduction in the United States over the last twelve months of unit dose laundry detergent by various manufacturers, including the Company, the laundry detergent category has declined by approximately 2%. However, the Company’s laundry detergent sales have increased, more than offsetting the impact of the total laundry category decline. Although there are indications that the impact of unit dose sales on total detergent sales is stabilizing, there is no assurance that the category will not decline further or that the Company will be able to offset any such category declines.

Consumer Domestic income before income taxes for the first quarter of 2013 was $134.0 million, a $21.8 million increase as compared to the first quarter of 2012. The increase is due primarily to the impact of higher sales volumes, the contribution from the Avid Health acquisition, favorable manufacturing costs resulting from productivity improvement projects, partially offset by the effect of unfavorable product mix and pricing and higher interest expense.

### Consumer International

Consumer International net sales were $129.3 million in the first quarter of 2013, an increase of $7.9 million or 6.5% as compared to the same period in 2012. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended March 31, 2013 |
| --- | ---: |
| Product volumes sold | 6.2% |
| Pricing/Product mix | (1.0%) |
| Foreign exchange rate fluctuations | (1.3%) |
| Acquired product lines(1) | 2.6% |
| **Net Sales increase** | **6.5%** |

(1) On October 1, 2012, the Company acquired Avid Health. Net sales of acquired product lines subsequent to the acquisition are included in the Company’s segment results.

Higher sales volumes occurred principally in Mexico, United Kingdom and Australia. Higher U.S. exports also contributed to the sales increase.

Consumer International income before income taxes was $21.6 million in the first quarter of 2013, a decrease of $0.2 million compared to the same period in 2012. The change is primarily due to the effect of lower prices and unfavorable product mix, unfavorable foreign exchange rates and higher interest expense partially offset by higher sales volume, the contribution from the Avid acquisition and manufacturing productivity gains.

### Specialty Products

SPD net sales were $59.0 million for the first quarter of 2013, an increase of $0.4 million, or 0.7% as compared to 2012. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended March 31, 2013 |
| --- | ---: |
| Product volumes sold | (0.4%) |
| Pricing/Product mix | 1.2% |
| Foreign exchange rate fluctuations | (1.8%) |
| Sales in anticipation of information systems upgrade | 1.7% |
| **Net Sales increase** | **0.7%** |

The net sales increase reflects higher pricing in performance products partially offset by reduced product sales of certain animal nutrition products. The increase in net sales is also due to the adverse impact in the first quarter of 2012 of a timing shift in customer orders from the first quarter of 2012 to the fourth quarter of 2011 in anticipation of the January 1, 2012 information systems upgrade in the U.S.

SPD income before income taxes was $7.0 million in the first quarter of 2013, an increase of $0.3 million as compared to the same period in 2012. The increase in the income before income taxes for 2013 primarily reflects higher selling prices partially offset by lower sales volume and changes in foreign exchange rates.

### Liquidity and Capital Resources

As of March 31, 2013, the Company had $259.6 million in cash, $19.7 million in marketable securities maturing in September 2013, approximately $250 million available through its revolving credit facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $500 million, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in prime money market funds.

As of March 31, 2013, the amount of cash, cash equivalents and marketable securities, included in the Company’s assets, that was held by foreign subsidiaries was approximately $168.1 million. If these funds are needed for operations in the U.S., the Company will be required to accrue and pay taxes in the U.S. to repatriate these funds. However, the Company’s intent is to permanently reinvest these funds outside the U.S., and the Company does not currently expect to repatriate them to fund operations in the U.S.

In March 2013, the Company invested approximately $19.7 million of its available cash at one of its international subsidiaries in marketable securities that mature on September 5, 2013. Marketable securities consist of a guaranteed investment certificate with a financial institution with a maturity of greater than three months when purchased. This certificate offers a better rate of return than the Company currently experiences with its cash and cash equivalent investments that are less than three months.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for our products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 (the “Form 10-K”).) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenants in its principal credit facility because the Company currently is, and anticipates that it will continue to be, in compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Credit Agreement. These financial ratios are discussed in more detail in this section under “Certain Financial Covenants.”

On January 30, 2013, the Board of Directors increased the Company’s regular quarterly dividend from $0.24 per share to $0.28 per share, equivalent to an annual dividend rate of $1.12 per share, commencing with the dividend payable on March 1, 2013 to stockholders of record at the close of business on February 15, 2013. The higher dividend raises the Company’s annualized dividend payout from approximately $135 million to approximately $156 million.

In January 2013, the Company purchased approximately 0.9 million shares of common stock at an aggregate cost of approximately $50 million under its share repurchase program.

The Company anticipates that its cash from operations, together with its current borrowing capacity, will be sufficient to meet its capital expenditure program costs, which are expected to be approximately $85 million in 2013, fund its stock repurchase program to the extent implemented by management and pay dividends at the latest approved rate. Cash may be used for acquisitions that would complement the Company’s existing product lines or geographic markets.

#### Net Debt

The Company had outstanding total debt of $853.3 million and cash and marketable securities of $279.3 million at March 31, 2013, resulting in net debt of $574.0 million at March 31, 2013. This compares to total debt of $903.2 million and cash of $343.0 million, resulting in net debt of $560.2 million at December 31, 2012. Net debt is defined as cash and marketable securities less total debt.

#### Cash Flow Analysis

*(In millions)*

|  | Three Months Ending March 31, 2013 | March 31, 2012 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$72.3** | $113.9 |
| Net cash used in investing activities | **$(33.3)** | $(18.5) |
| Net cash used in financing activities | **$(118.9)** | $(117.4) |

**Net Cash Provided by Operating Activities –** The Company’s net cash provided by operating activities in the first three months of 2013 decreased $41.6 million to $72.3 million as compared to 2012. The Company was able to defer the fourth quarter 2012 federal tax payment of approximately $36.0 million to the first quarter of 2013 as allowed by the IRS due to the impact of Hurricane Sandy. Additionally, increases in other components of working capital were partially offset by higher net income.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first three months of 2013 was $33.3 million, reflecting $10.4 million of property, plant and equipment expenditures, $19.7 million invested in marketable securities and a $3.2 million investment in Natronx.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first three months of 2013 was $118.9 million, principally reflecting $50.0 million of repayments of commercial paper, $50.3 million of repurchases of common stock (the “Common Stock”) of the Company and $38.6 million of cash dividends, partially offset by $9.3 million of proceeds and tax benefits from stock option exercises and the receipt of an incentive payment of $10.7 million related to the financing lease for the Company’s new corporate headquarters.

### Certain Financial Covenants

“Consolidated EBITDA” (referred to below as “Adjusted EBITDA”) is a component of the financial covenants contained in, and is defined in, the Company’s Credit Agreement. Financial covenants include a leverage ratio (total debt to Adjusted EBITDA) and an interest coverage ratio (Adjusted EBITDA to total interest expense), which if not met, could result in an event of default and trigger the early termination of the Credit Agreement. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities, which is determined in accordance with accounting principles generally accepted in the U.S. The Company’s leverage ratio for the three months ended March 31, 2013 was 1.3, which is below the maximum of 3.5 permitted under the Credit Agreement, and the interest coverage ratio for the three months ended March 31, 2013 was 63.5, which is above the minimum of 3.0 permitted under the Credit Agreement.

### New Accounting Pronouncements

In February 2013, the Financial Accounting Standards Board (“FASB”) issued new guidance for the reporting of amounts reclassified out of accumulated other comprehensive income. The new guidance requires the presentation of amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. The adoption of of the new pronouncement did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s financial position, results of operations or cash flows.

## Market risk

As filed, 3,202 characters.

### Market risk

#### Interest Rate Risk

The Company had outstanding total debt at March 31, 2013 of $853.3 million, of which 76% has a fixed weighted average interest rate of 3.06% and the remaining 24% constituted principally commercial paper issued by the Company that currently has an interest rate of less than 0.5%. The Company periodically considers entering into hedge agreements to mitigate the interest rate risk.

#### Diesel Fuel Hedge

The Company uses independent freight carriers to deliver its products. These carriers charge the Company a basic rate per mile that is subject to a mileage surcharge for diesel fuel price increases. During 2012 and 2013, the Company entered into hedge agreements with financial counterparties to mitigate the volatility of diesel fuel prices and related fuel surcharges, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment reflecting the variable common carriers’ mileage surcharge. The floating rate payment is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index price during the applicable month and is designed to offset any increase or decrease in fuel surcharge payments that the Company pays to it common carriers. As of March 31, 2013, the agreements are expected to cover approximately 45% of the Company’s estimated diesel fuel requirements for 2013 and approximately 28% of the Company’s estimated diesel fuel requirements for 2014. These agreements qualify for hedge accounting. Therefore, changes in the fair value of diesel fuel hedge agreements are recorded in Accumulated Other Comprehensive Income on the balance sheet.

#### Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company, from time to time, enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed intercompany sales or purchases denominated in the U.S. Dollar, Canadian Dollar, British Pound and Euro. The Company has entered into forward exchange contracts to protect it from the risk that, due to changes in currency exchange rates, it would be adversely affected by net cash outflows.

#### Equity Derivatives

The Company has entered into equity derivative contracts covering its own stock in order to minimize its liability in its Executive Deferred Compensation Plan, resulting from changes in quoted fair values of Company stock, to participants who have investments under that plan in a notional Company stock fund. The contracts are settled in cash. Since the equity derivatives do not qualify for hedge accounting, the Company is required to mark the agreements to market throughout the life of the agreements and record changes in fair value in the consolidated statement of income.

## Controls and procedures

As filed, 4,920 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s (the “Commission”) rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This Report contains forward-looking statements, including, among others, statements relating to sales and earnings growth; the effect of product mix; volume growth including the effects of new products; the impact of unit dose laundry detergent; consumer demand and spending; the effects of competition; earnings per share; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; cost savings programs; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; the Company’s stock repurchase programs; the impact of acquisitions including the acquisition of Avid Health; capital expenditures; the sales impact related to the Company’s information systems upgrade; the effective tax rate; the impact of tax audits; tax changes and the lapse of applicable statutes of limitations; facility restructuring charges; environmental and regulatory matters; availability of raw materials; the effect of the credit environment on the Company’s liquidity and capital expenditures; the Company’s fixed rate debt; compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Company’s credit agreement; the Company’s commercial paper program; sufficiency of cash flows from operations; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; payment of dividends; expected cash contributions to pension plans; investments in the Natronx joint venture; and adequacy of trona reserves. These statements represent the intentions, plans, expectations and beliefs of the Company, and are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that might cause such differences include a decline in market growth and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U.S. federal securities laws. You are advised, however, to consult any further disclosures we make on related subjects in the Company’s filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed May 2, 2013.
Source: SEC EDGAR, the filing index for accession 0001193125-13-195736. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
